Format

Send to

Choose Destination
See comment in PubMed Commons below
Vaccine. 2011 Oct 26;29(46):8205-14. doi: 10.1016/j.vaccine.2011.08.059. Epub 2011 Sep 5.

Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission.

Author information

1
Polio Eradication Initiative, World Health Organization, Geneva, Switzerland. okayasuhi@who.int

Abstract

Since the resolution of the World Assembly in 1988 to eradicate polio globally, substantial progress toward this target has been achieved, but the final goal remains elusive. India and other tropical developing countries present a unique challenge because of the much lower oral poliovirus vaccine (OPV) immunogenicity compared to industrialized countries, both in terms of humoral and mucosal immunity. To overcome this challenge, further research is needed to elucidate the causes for the suboptimal OPV immunogenicity, better defining the optimal vaccine schedules and delivery strategies, developing and evaluating adjuvants to boost OPV immunogenicity, and improving the methods for directly measuring mucosal immunity.

PMID:
21896299
DOI:
10.1016/j.vaccine.2011.08.059
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center